BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19279217)

  • 1. A tumor suppressor function for caspase-2.
    Ho LH; Taylor R; Dorstyn L; Cakouros D; Bouillet P; Kumar S
    Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5336-41. PubMed ID: 19279217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caspase-2 deficiency promotes aberrant DNA-damage response and genetic instability.
    Dorstyn L; Puccini J; Wilson CH; Shalini S; Nicola M; Moore S; Kumar S
    Cell Death Differ; 2012 Aug; 19(8):1288-98. PubMed ID: 22498700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.
    Parsons MJ; McCormick L; Janke L; Howard A; Bouchier-Hayes L; Green DR
    Cell Death Differ; 2013 Sep; 20(9):1174-82. PubMed ID: 23645210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressing function of caspase-2 requires catalytic site Cys-320 and site Ser-139 in mice.
    Ren K; Lu J; Porollo A; Du C
    J Biol Chem; 2012 Apr; 287(18):14792-802. PubMed ID: 22396545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase-2 as a tumour suppressor.
    Puccini J; Dorstyn L; Kumar S
    Cell Death Differ; 2013 Sep; 20(9):1133-9. PubMed ID: 23811850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caspase-2: killer, savior and safeguard--emerging versatile roles for an ill-defined caspase.
    Krumschnabel G; Manzl C; Villunger A
    Oncogene; 2009 Sep; 28(35):3093-6. PubMed ID: 19581929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unexpected role for caspase-2 in neuroblastoma.
    Dorstyn L; Puccini J; Nikolic A; Shalini S; Wilson CH; Norris MD; Haber M; Kumar S
    Cell Death Dis; 2014 Aug; 5(8):e1383. PubMed ID: 25144718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired TNFalpha-induced A20 expression in E1A/Ras-transformed cells.
    Huang HL; Yeh WC; Lai MZ; Mirtsos C; Chau H; Chou CH; Benchimol S
    Br J Cancer; 2009 Nov; 101(9):1555-64. PubMed ID: 19826422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caspase-2 is required for cell death induced by cytoskeletal disruption.
    Ho LH; Read SH; Dorstyn L; Lambrusco L; Kumar S
    Oncogene; 2008 May; 27(24):3393-404. PubMed ID: 18193089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor prone phenotype of mice deficient in a novel apoptosis-inducing gene, drs.
    Tambe Y; Yoshioka-Yamashita A; Mukaisho K; Haraguchi S; Chano T; Isono T; Kawai T; Suzuki Y; Kushima R; Hattori T; Goto M; Yamada S; Kiso M; Saga Y; Inoue H
    Carcinogenesis; 2007 Apr; 28(4):777-84. PubMed ID: 17088259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A direct link between expression of urokinase plasminogen activator receptor, growth rate and oncogenic transformation in mouse embryonic fibroblasts.
    Mazzieri R; Furlan F; D'Alessio S; Zonari E; Talotta F; Verde P; Blasi F
    Oncogene; 2007 Feb; 26(5):725-32. PubMed ID: 16878153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation.
    Scott CL; Schuler M; Marsden VS; Egle A; Pellegrini M; Nesic D; Gerondakis S; Nutt SL; Green DR; Strasser A
    J Cell Biol; 2004 Jan; 164(1):89-96. PubMed ID: 14709542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
    Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
    Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice.
    Xu Y; Yang EM; Brugarolas J; Jacks T; Baltimore D
    Mol Cell Biol; 1998 Jul; 18(7):4385-90. PubMed ID: 9632822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition.
    Soengas MS; Alarcón RM; Yoshida H; Giaccia AJ; Hakem R; Mak TW; Lowe SW
    Science; 1999 Apr; 284(5411):156-9. PubMed ID: 10102818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. zVAD-fmk upregulates caspase-9 cleavage and activity in etoposide-induced cell death of mouse embryonic fibroblasts.
    Rodríguez-Enfedaque A; Delmas E; Guillaume A; Gaumer S; Mignotte B; Vayssière JL; Renaud F
    Biochim Biophys Acta; 2012 Aug; 1823(8):1343-52. PubMed ID: 22613767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unpredictable caspase-2: what can it do?
    Vakifahmetoglu-Norberg H; Zhivotovsky B
    Trends Cell Biol; 2010 Mar; 20(3):150-9. PubMed ID: 20061149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling.
    Dorstyn L; Hackett-Jones E; Nikolic A; Norris MD; Lim Y; Toubia J; Haber M; Kumar S
    Cell Death Dis; 2019 Jan; 10(2):56. PubMed ID: 30670683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53.
    Li Z; Xiong Y
    Oncogene; 2017 Sep; 36(36):5212-5218. PubMed ID: 28481879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation-selective apoptotic program triggered by farnesyltransferase inhibitors requires Bin1.
    DuHadaway JB; Du W; Donover S; Baker J; Liu AX; Sharp DM; Muller AJ; Prendergast GC
    Oncogene; 2003 Jun; 22(23):3578-88. PubMed ID: 12789266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.